A detailed history of Arizona State Retirement System transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 22,716 shares of APLS stock, worth $596,749. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,716
Previous 22,013 3.19%
Holding current value
$596,749
Previous $844,000 22.39%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$28.84 - $41.15 $20,274 - $28,928
703 Added 3.19%
22,716 $655,000
Q2 2024

Aug 05, 2024

BUY
$38.07 - $59.71 $94,147 - $147,662
2,473 Added 12.66%
22,013 $844,000
Q1 2024

May 07, 2024

SELL
$55.39 - $72.47 $193,865 - $253,645
-3,500 Reduced 15.19%
19,540 $1.15 Million
Q4 2023

Jan 24, 2024

SELL
$37.14 - $64.82 $6,350 - $11,084
-171 Reduced 0.74%
23,040 $1.38 Million
Q3 2023

Nov 06, 2023

BUY
$23.65 - $89.22 $12,794 - $48,268
541 Added 2.39%
23,211 $882,000
Q2 2023

Aug 01, 2023

SELL
$76.68 - $93.31 $227,049 - $276,290
-2,961 Reduced 11.55%
22,670 $2.07 Million
Q1 2023

Apr 27, 2023

BUY
$46.59 - $66.96 $38,669 - $55,576
830 Added 3.35%
25,631 $1.69 Million
Q4 2022

Feb 07, 2023

BUY
$43.24 - $61.04 $71,043 - $100,288
1,643 Added 7.09%
24,801 $1.28 Million
Q3 2022

Nov 07, 2022

BUY
$44.76 - $69.66 $88,177 - $137,230
1,970 Added 9.3%
23,158 $1.58 Million
Q2 2022

Jul 28, 2022

BUY
$35.07 - $59.21 $16,868 - $28,480
481 Added 2.32%
21,188 $958,000
Q1 2022

May 04, 2022

BUY
$35.46 - $54.12 $3,191 - $4,870
90 Added 0.44%
20,707 $1.05 Million
Q4 2021

Feb 04, 2022

BUY
$30.74 - $49.16 $128,247 - $205,095
4,172 Added 25.37%
20,617 $975,000
Q3 2021

Nov 12, 2021

BUY
$31.4 - $69.84 $1,852 - $4,120
59 Added 0.36%
16,445 $542,000
Q2 2021

Aug 02, 2021

SELL
$40.9 - $64.9 $6,094 - $9,670
-149 Reduced 0.9%
16,386 $1.04 Million
Q1 2021

May 06, 2021

BUY
$40.8 - $57.39 $3,712 - $5,222
91 Added 0.55%
16,535 $710,000
Q4 2020

Jan 28, 2021

SELL
$30.79 - $57.2 $54,898 - $101,987
-1,783 Reduced 9.78%
16,444 $941,000
Q3 2020

Nov 05, 2020

BUY
$25.89 - $33.65 $119,793 - $155,698
4,627 Added 34.02%
18,227 $550,000
Q2 2020

Aug 04, 2020

SELL
$24.8 - $38.49 $4,538 - $7,043
-183 Reduced 1.33%
13,600 $444,000
Q1 2020

May 05, 2020

BUY
$17.91 - $44.33 $246,853 - $611,000
13,783 New
13,783 $369,000

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.89B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.